CNBS logo

Amplify Seymour Cannabis ETF (CNBS)

Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Amplify Seymour Cannabis ETF (CNBS) ist im Financial Services-Sektor taetig, zuletzt notiert bei $ mit einer Marktkapitalisierung von 0. Bewertet mit 44/100 (vorsichtig) bei Wachstumspotenzial, finanzieller Gesundheit und Momentum.

Zuletzt analysiert: 18. März 2026
44/100 KI-Bewertung

Amplify Seymour Cannabis ETF (CNBS) Finanzdienstleistungsprofil

HauptsitzWheaton, US
IPO-Jahr2019

Amplify Seymour Cannabis ETF (CNBS) offers investors diversified exposure to the U.S. cannabis industry, encompassing plant cultivation, support services, and ancillary businesses. As an actively managed ETF, CNBS aims to achieve capital appreciation by strategically allocating investments across the cannabis value chain, distinguishing itself through its focused U.S. market approach.

Datenherkunft | Finanzdaten Quantitative Analyse NASDAQ Analyse: 18. März 2026

Investmentthese

Amplify Seymour Cannabis ETF (CNBS) presents a focused investment opportunity within the U.S. cannabis market. With a market capitalization of $0.08 billion and a beta of 0.18, CNBS offers exposure to a high-growth sector with relatively low volatility compared to the broader market. The primary value driver is the continued expansion and legalization of cannabis across U.S. states, creating new market opportunities for companies within the cannabis ecosystem. Upcoming catalysts include potential federal regulatory reforms and increasing consumer acceptance of cannabis products. However, potential risks include regulatory uncertainty, competition from established players, and market volatility. The ETF's active management strategy aims to capitalize on these growth opportunities while mitigating risks, making it a potentially noteworthy option for investors seeking exposure to the U.S. cannabis market.

Basierend auf FMP-Finanzdaten und quantitativer Analyse

Wichtige Highlights

  • Market Cap: $0.08B indicates the fund's size and potential for growth within the cannabis sector.
  • Beta: 0.18 suggests lower volatility compared to the broader market, potentially offering a more stable investment in a high-growth sector.
  • Actively Managed: The fund's active management allows for strategic adjustments based on market conditions and regulatory changes, potentially enhancing returns.
  • U.S. Focus: CNBS provides targeted exposure to the U.S. cannabis market, capitalizing on the growth potential within the evolving U.S. regulatory landscape.
  • Diversified Exposure: CNBS invests across the cannabis ecosystem, encompassing companies involved in cannabis cultivation, support services, and ancillary businesses, mitigating risk through diversification.

Wettbewerber & Vergleichsunternehmen

Staerken

  • Diversified exposure to the U.S. cannabis market.
  • Active management strategy.
  • Focus on U.S.-based companies.
  • Established track record.

Schwaechen

  • Relatively small market capitalization.
  • Concentrated exposure to the cannabis industry.
  • Dependence on regulatory developments.
  • Potential for high volatility.

Katalysatoren

  • Upcoming: Potential federal regulatory reforms regarding cannabis.
  • Ongoing: Increasing legalization of cannabis at the state level.
  • Ongoing: Expansion of cannabis-related products and services.
  • Ongoing: Growing consumer acceptance of cannabis.

Risiken

  • Potential: Regulatory uncertainty and changes in cannabis laws.
  • Potential: Competition from established players in the cannabis industry.
  • Potential: Market volatility and fluctuations in cannabis stock prices.
  • Potential: Changes in consumer preferences and demand for cannabis products.
  • Ongoing: Dependence on regulatory developments for growth.

Wachstumschancen

  • Increased Legalization: The ongoing legalization of cannabis at the state level in the U.S. presents a significant growth opportunity for CNBS. As more states legalize cannabis for medical or recreational use, the market size expands, creating new opportunities for companies within the cannabis ecosystem. This trend is expected to continue over the next 3-5 years, driving growth for CNBS and its underlying holdings. The total addressable market for cannabis in the U.S. is projected to reach $50 billion by 2028, providing a substantial runway for growth.
  • Federal Regulatory Reform: Potential federal regulatory reforms, such as the legalization or decriminalization of cannabis at the federal level, could be a major catalyst for the cannabis industry and CNBS. Such reforms would remove significant barriers to interstate commerce and investment, opening up new opportunities for growth and expansion. While the timing of federal reforms is uncertain, the potential impact is substantial, making it a key growth driver for CNBS.
  • Expansion of Cannabis-Related Products and Services: The cannabis industry is constantly evolving, with new products and services emerging to meet changing consumer demands. CNBS is positioned to benefit from this trend by investing in companies that are developing innovative cannabis-related products and services, such as edibles, beverages, and wellness products. This expansion of the cannabis ecosystem creates new revenue streams and growth opportunities for CNBS and its underlying holdings.
  • Increased Consumer Acceptance: As societal attitudes towards cannabis continue to evolve, consumer acceptance is increasing, driving demand for cannabis products and services. This trend is particularly evident among younger generations, who are more likely to view cannabis favorably. CNBS is positioned to benefit from this trend by investing in companies that are catering to the growing demand for cannabis products and services among consumers. The increasing consumer acceptance of cannabis is expected to drive long-term growth for the industry and CNBS.
  • Strategic Acquisitions and Partnerships: Companies within the cannabis industry are increasingly engaging in strategic acquisitions and partnerships to expand their market reach, enhance their product offerings, and gain access to new technologies. CNBS is positioned to benefit from this trend by investing in companies that are actively pursuing strategic acquisitions and partnerships. These deals can create synergies, improve efficiency, and drive growth for CNBS and its underlying holdings.

Chancen

  • Increased legalization of cannabis at the state and federal levels.
  • Expansion of cannabis-related products and services.
  • Growing consumer acceptance of cannabis.
  • Strategic acquisitions and partnerships.

Risiken

  • Regulatory uncertainty.
  • Competition from established players.
  • Market volatility.
  • Changes in consumer preferences.

Wettbewerbsvorteile

  • Diversified exposure to the U.S. cannabis market.
  • Active management strategy to optimize returns.
  • Focus on U.S.-based companies.
  • Established track record in the cannabis ETF space.

Ueber CNBS

Amplify Seymour Cannabis ETF (CNBS) is an actively managed exchange-traded fund (ETF) designed to provide investors with diversified exposure to the burgeoning U.S. cannabis industry. Launched with the objective of capital appreciation, CNBS strategically invests across the cannabis ecosystem, encompassing companies involved in cannabis cultivation, support services, and ancillary businesses. The ETF's investment strategy focuses exclusively on U.S.-based companies, capitalizing on the growth potential within the evolving U.S. cannabis market. CNBS actively manages its portfolio, adapting to market dynamics and regulatory changes to optimize investment outcomes. By offering a diversified portfolio of cannabis-related companies, CNBS seeks to mitigate risk while capturing the upside potential of this rapidly expanding sector. The fund's active management approach allows for strategic adjustments based on market conditions and regulatory developments, aiming to enhance returns for investors seeking exposure to the U.S. cannabis industry. CNBS provides a vehicle for investors to participate in the growth of the U.S. cannabis market through a diversified and actively managed ETF structure.

Was das Unternehmen tut

  • Invests in U.S. companies involved in cannabis cultivation.
  • Provides exposure to companies supporting the cannabis industry.
  • Includes companies providing ancillary services to the cannabis sector.
  • Actively manages its portfolio to optimize investment outcomes.
  • Seeks capital appreciation through strategic investments.
  • Offers a diversified portfolio of cannabis-related companies.
  • Adapts to market dynamics and regulatory changes.

Geschaeftsmodell

  • Generates revenue through management fees charged to investors.
  • Invests in a diversified portfolio of cannabis-related companies.
  • Actively manages its portfolio to maximize returns.
  • Distributes capital gains to investors.

Branchenkontext

The asset management industry is undergoing significant transformation, driven by technological advancements, changing investor preferences, and increasing regulatory scrutiny. ETFs like CNBS are gaining popularity as investors seek diversified exposure to specific sectors and themes. The cannabis industry, while still nascent, is experiencing rapid growth due to increasing legalization and acceptance. CNBS is positioned to capitalize on this growth by providing investors with a convenient and diversified way to access the U.S. cannabis market. The competitive landscape includes other ETFs and investment vehicles focused on the cannabis sector, each with its own investment strategy and risk profile.

Wichtige Kunden

  • Retail investors seeking exposure to the cannabis industry.
  • Institutional investors looking for diversified cannabis investments.
  • Financial advisors seeking to add cannabis exposure to client portfolios.
KI-Zuversicht: 81% Aktualisiert: 18. März 2026

Finanzdaten

Chart & Info

Amplify Seymour Cannabis ETF (CNBS) Aktienkurs: Price data unavailable

Aktuelle Nachrichten

Analystenkonsens

Konsens-Bewertung

Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer CNBS.

Kursziele

Wall-Street-Kurszielanalyse fuer CNBS.

MoonshotScore

44/100

Was bedeutet diese Bewertung?

Der MoonshotScore bewertet das Wachstumspotenzial von CNBS auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.

CNBS Financial Services Aktien-FAQ

What are the key factors to evaluate for CNBS?

Amplify Seymour Cannabis ETF (CNBS) currently holds an AI score of 44/100, indicating low score. Key strength: Diversified exposure to the U.S. cannabis market.. Primary risk to monitor: Potential: Regulatory uncertainty and changes in cannabis laws.. This is not financial advice.

How frequently does CNBS data refresh on this page?

CNBS prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven CNBS's recent stock price performance?

Recent price movement in Amplify Seymour Cannabis ETF (CNBS) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Diversified exposure to the U.S. cannabis market.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider CNBS overvalued or undervalued right now?

Determining whether Amplify Seymour Cannabis ETF (CNBS) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying CNBS?

Before investing in Amplify Seymour Cannabis ETF (CNBS), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Why might investors consider adding CNBS to a portfolio?

Potential reasons to consider Amplify Seymour Cannabis ETF (CNBS) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Diversified exposure to the U.S. cannabis market.. Additionally: Active management strategy.. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.

Can I buy fractional shares of CNBS?

Yes, most major brokerages offer fractional shares of Amplify Seymour Cannabis ETF (CNBS) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track CNBS's earnings and financial reports?

Amplify Seymour Cannabis ETF (CNBS) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for CNBS earnings announcements is recommended.

Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.

Offizielle Ressourcen

Analyse aktualisiert am KI-Bewertung taeglich aktualisiert
Datenquellen & Methodik
Marktdaten bereitgestellt von Financial Modeling Prep & Yahoo Finance. KI-Analyse durch proprietaere Algorithmen von Stock Expert AI. Technische Indikatoren nach branchenueblichen Berechnungsstandards. Zuletzt aktualisiert: .

Daten dienen ausschliesslich zu Informationszwecken.

Analysehinweise
  • AI analysis pending for CNBS.
  • The cannabis industry is subject to evolving regulations and market conditions.
Datenquellen

Popular Stocks